-
Voreloxin Hydrochloride
- names:
Voreloxin Hydrochloride
- CAS号:
175519-16-1
MDL Number: - MF(分子式): C18H20ClN5O4S MW(分子量): 437.9
- EINECS: Reaxys Number:
- Pubchem ID: Brand:BIOFOUNT
| 货品编码 | 规格 | 纯度 | 价格 (¥) | 现价(¥) | 特价(¥) | 库存描述 | 数量 | 总计 (¥) |
|---|---|---|---|---|---|---|---|---|
| YZM001372-10mg | 10mg | 99.7% | ¥ 3240.00 | ¥ 3240.00 | 2-3天 | ¥ 0.00 | ||
| YZM001372-5mg | 5mg | 99.7% | ¥ 1820.00 | ¥ 1820.00 | 2-3天 | ¥ 0.00 |
| 中文别名 | |
| 英文别名 | Voreloxin Hydrochloride |
| CAS号 | 175519-16-1 |
| Inchi | |
| InchiKey | |
| 分子式 Formula | C18H20ClN5O4S |
| 分子量 Molecular Weight | 437.9 |
| 溶解度Solubility | 生物体外In Vitro:DMSO溶解度2 mg/mL(4.57 mM;ultrasonic and warming and heat to 60°C) |
| 性状 | |
| 储藏条件 Storage conditions | 粉末Powder: -20°C 3 years年 4°C 2 years年 / In solvent溶液中:-80°C 6 months月 -20°C 1 month月 |
| 产品说明 | |
| Introduction | Voreloxin Hydrochloride is a firstnlasstopoisomerase IIinhibitor that intercalates DNA and induces siteelective DNA DSB, G2 arrest, and apoptosis. |
| Application1 | |
| Application2 | |
| Application3 |
Voreloxin Hydrochloride 是一种有效的新创的拓扑异构酶 II (topoisomerase II) 抑制剂,能够诱导 DNA 双链断裂,阻滞 G2 期,最终细胞凋亡。Voreloxin Hydrochloride is a first-in-classtopoisomerase IIinhibitor that intercalates DNA and induces site-selective DNA DSB, G2 arrest, and apoptosis.
【1】.Hotinski AK, et al. Vosaroxin is a novel topoisomerase-II inhibitor with efficacy in relapsed and refractory acute myeloid leukaemia. Expert Opin Pharmacother. 2015 Jun;16(9):1395-402.
【2】.Scatena CD, et al. Voreloxin, a first-in-class anticancer quinolone derivative, acts synergistically with cytarabine in vitro and induces bone marrow aplasia in vivo. Cancer Chemother Pharmacol. 2010 Oct;66(5):881-8.
【3】.Walsby EJ, et al. The topoisomerase II inhibitor voreloxin causes cell cycle arrest and apoptosis in myeloid leukemia cells and acts in synergy with cytarabine. Haematologica. 2011 Mar;96(3):393-9.
【2】.Scatena CD, et al. Voreloxin, a first-in-class anticancer quinolone derivative, acts synergistically with cytarabine in vitro and induces bone marrow aplasia in vivo. Cancer Chemother Pharmacol. 2010 Oct;66(5):881-8.
【3】.Walsby EJ, et al. The topoisomerase II inhibitor voreloxin causes cell cycle arrest and apoptosis in myeloid leukemia cells and acts in synergy with cytarabine. Haematologica. 2011 Mar;96(3):393-9.
对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
- 相关产品
-
< >
- 推荐产品
-
< >
- 最新产品
-
< >
新闻
抱歉,暂无数据!


购物车 


